Chelsea And Westminster Nhs Foundation Trust

This study followed 200 transgender and non-binary people living with HIV across Europe for 18 months. Researchers collected data from routine blood tests to see how well HIV treatment was working. The goal is to use these findings to create better treatment guidelines and design…

This completed Phase 1 trial studied 16 healthy volunteers to see if the HIV drug dolutegravir affects insulin sensitivity, fat metabolism, and hormone levels. Researchers aim to understand why some HIV patients gain weight while taking this medication. Participants took dolutegr…